The pharmacology of cardiac drugs is an immense topic and reducing its components to a
single chapter is a challenging task. This chapter presents a broad overview of a wide …

In 1987, some 30 years ago, the journal Cardiovascular Drugs and Therapy was founded by
two eminent cardiologists, Henry N. Neufeld and Lionel H. Opie. It was initially sponsored by …

Drugs used in cardiology may be categorised in various ways, either alphabetically, by
mode of action, frequency of use, or pharmacological activity. In this presentation, the most …

This is a loose-leaf book that reviews the pharmacology of practically all drugs used in
cardiology in the United States. At the beginning of each of the 13 chapters there is an …

This review presents a brief overview of some of the many exciting developments that are
taking place in the field of cardiovascular pharmacology. Research continues to progress at …

While all interventional cardiologists have access to pharmacopeial texts and databases, it
is essential that they remain up to date on the growing number of pharmacological agents in …

Introduction espite the large number of pharmacologic agents available for the treatment of
cardiovascular disease, the search for additional drugs and pharmacotherapeutic …

In any textbook, basic scientific knowledge, and the art of clinical practice should be brought
together in a rational manner and this volume on cardio vascular therapy attempts to …

This fourth edition of Current Cardiovascular Drugs is designed to provide an updated
practical compendium of current knowledge regarding cardiovascular drug therapy in a …

Catecholamines produce a wide range of effects mediated by the activation of
adrenoceptors. These receptors have been subclassified into 0t-and [S-receptors …